Login |
MissionThe current lack of harmonisation of malaria vaccine assay conduct coupled with the lack of an enabling environment for comparing research results leads to scepticism about the comparability of assay results. Assay harmonisation is a central priority to enable rational malaria vaccine design and for decision-making in vaccine development. The overall goal of this three year project is to develop harmonised assays to facilitate comparison of results and improve decision making on vaccine construct development, product characterisation, down selection of candidates and/or formulation, and clinical development plans. The project involves thirteen partner institutions and is funded by the European Commission's Framework Program 7 (FP7) as Coordination and Support Action, project number: 223126, with €1 000 000 and by additional complementary contributions from the PATH Malaria Vaccine Initiative and the Centers for Disease Control and Prevention. The official starting date of the project is 1st April 2009. NEWSCall for Action on Vaccine Development and Immunisation access for those most at needCall for Action on Vaccine Development and Immunisation access for those most at need On 16th April 2012, the European Union (EU) Vaccines Advocacy Coalition (EUVAC) published a Call for Action on Vaccine Development and Immunisation access for those most at need. EUVAC, of which EVI is part, is a policy driven advocacy and campaigns network that strives to raise the profile of vaccines and ensure the EU institutions address the issue of vaccine development and immunisation access for developing countries. The specific text can be found on pages 20-21 at http://www.theparliament.com/digimag/immunisation but the whole brochure is worth reading! The Parliament Magazine is widely recognised as the magazine for Members of European Parliament (MEPs), by MEPs. Welcome to a new member of EVI StaffNicola Katrin Viebig takes up her duties as Project Manager on 2 May. EVI extends a warm welcome to Nicola, who will be working on projects funded by EDCTP, EC, and EVI. TRANSVAC Project: 1st Workshop on Animal Models, May 12, 2011, NLTRANSVAC offers a free workshop on harmonisation and standardisation of animal models in vaccine development. Towards validated assays for key immunological outcomesTo highlight the importance of assay harmonisation in malaria vaccine development, the OPTIMALVAC Consortium has published the position paper “Towards validated assays for key immunological outcomes”. Vaccine 29 (2011) 3093–3095. 
|
NewsTo read more about upcoming eventsplease go to ►Announcements. For information on past meetingsplease go to ►Meetings.
|
